Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.109732 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Zhongmei Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China; Department of …. Hauptthemen laut MEDLINE: Pre-Eclampsia, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Failures in invasive extravillous trophoblasts (EVTs) migration into the maternal uterus have been noticed in preeclampsia (PE). Human umbilical cord mesenchymal stem cell (hUCMSC)-derived extracellular vesicles (EVs) have been highlighted for the role as a potential therapeutic method in PE. This study intends to investigate the mechanistic basis of hUCMSCs-derived EVs loaded with bioinformatically identified TFCP2 in the activities of EVTs of PE. METHODS: Primary human EVTs were exposed to hypoxic/reoxygenation (H/R) to mimic the environment encountered in PE. The in vivo PE-like phenotypes were induced in mice by reduced uterine perfusion pressure (RUPP) surgery. CCK-8, Transwell and flow cytometry assays were performed to detect proliferation, migration, invasion and apoptosis of H/R-exposed EVTs. More importantly, EVs were extracted from hUCMSCs and transduced with ectopically expressed TFCP2, followed by co-culture with EVTs. RESULTS: TFCP2 was found to be down-regulated in the preeclamptic placental tissues and in H/R-exposed EVTs. hUCMSCs-EVs loaded with TFCP2 activated the Wnt/β-catenin pathway, thereby promoting the proliferative, migratory, and invasive potential of EVTs. Furthermore, overexpression of TFCP2 alleviated PE-like phenotypes in mice, which was associated with activated Wnt/β-catenin pathway. CONCLUSION: From our data we conclude that hUCMSCs-EVs overexpressing TFCP2 may be instrumental for the therapeutic targeting and clinical management of PE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China; Department of Obstetrics and Gynecology, Sichuan Provincial People's Hospital, Schoo…
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China.
- Department of Obstetrics and Gynecology, Sichuan Provincial People's Hospital, School of Medicine UESTC, Chengdu 610072, P. R. China; Sichuan Translational Medicine Research Hospital, Chinese Academy of Sciences, Chengd…
- Department of Obstetrics and Gynecology, Chengdu Second People's Hospital, Chengdu 610021, PR China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P. R. China. Electronic address: shannancqmu@163.com.
Zitieren
APA
Yang, Z., Jia, X., Deng, Q., Luo, M., Hou, Y., Yue, J., Mei, J., Shan, N., & Wu, Z. (2023). Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.109732
Vancouver
Yang Z, Jia X, Deng Q, Luo M, Hou Y, Yue J, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.109732
BibTeX
@article{Yang2023,
author = {Yang, Zhongmei and Jia, Xiaoyan and Deng, Qinyin and Luo, Mengdie and Hou, Yan and Yue, Jun and Mei, Jie and Shan, Nan and Wu, Zhao},
title = {Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.109732}
}
EUVIMED